brentuximab
seagen
['ptcl', 'lymsm']
recap of many negative ptcl trials, one positive (echelon-2, bv-chp, 's favourite), and a few still works in progress
#asco23 #lymsm 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem